Brought to you by 
Embrella Cardiovascular brings in $5.1mm through its Series B, adds on
15 Mar 2011
Executive Summary
Embrella Cardiovascular (developing a device that provides cerebral embolic protection during cardiovascular surgeries) has raised $5.1mm through its Series B round. First-time backer Bio-Star Ventures co-led the financing with current shareholder Medfocus Fund and were joined by new investor Edwards Lifesciences as well as 28 other new and returning private investors.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Embrella Cardiovascular brings in $5.1mm through its Series B, adds on
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice